John O'Shaughnessy Email & Phone Number

John O'Shaughnessy founded Matrix Surgical USA, a wholly owned subsidiary of Matrix Surgical Holdings, LLC, in 2012 and serves as its Chief Executive Officer. Headquartered in Atlanta, Georgia, Matrix Surgical USA is a pioneer in the design, development, manufacturing and commercialization of innovative biomaterials and surgical devices used in Craniomaxillofacial and Ophthalmic surgery. The Company's flagship product, OMNIPORE Surgical Implants, is cleared to market by the US FDA, carries the CE Mark, and is sold in more than 80 countries around the world.Before founding Matrix Surgical USA, Mr. O'Shaughnessy held numerous senior level management positions with Stryker (NYSE: SYK) and Porex Surgical, Inc (division of WebMD NASDAQ: WBMD) with General Management (P&L), Sales, Marketing & Business Development responsibilities. While with Porex Surgical, Inc., he created, staffed and lead two foreign subsidiaries in Munich, Germany and Shanghai, China which drove the firm's international revenue growth over 700% in a 12 year period. In 2001, Porex Surgical, Inc. received the President's E-Award from President George W. Bush in recognition of its outstanding export revenue growth from 1998 to 2001. Mr. O'Shaughnessy is a published author, a frequent contributor to the business press, and highly sought-after speaker/panelist on matters of globalization, entrepreneurship, startups, and the global medical technology market. He holds a Bachelor of Arts in Economics from the State University of New York at Potsdam and a Masters Degree in Business Administration from the J. Mack Robinson College of Business at Georgia State University. In 2006 he was the recipient of the Global Business Alumni Award from the J. Mack Robinson College of Business.Specialties: Globalization strategy, emerging markets and risk management, global branding, global sales channel management, strategic alliances, merger & acquisitions, talent recruitment and development, regulatory environments

Listed skills include Strategy, Medical Devices, Sales Operations, Product Development, and 53 others.